title: [Characteristic of early mucosal immune response in mice during intravaginal infection caused by Chlamydia muridarum].
abstract: OBJECTIVE
  Comparison of features of recruitment to infection focus of cells mediating early immune reactions in intravaginally infected mice that had previously received or not received covinan (progesterone analogue).
  
  
  METHODS
  A/Sn and BALB/c line mice were used in the study. C. muridarum strain Nigg infection was carried out intravaginally or intraperitoneally. For synchronization of sexual cycle a group of mice received subcutaneously a synthetic analogue of progesterone--proligeston (covinan) at a single dose of 33 mg/kg. Acute urogenital infection was evaluated by culture method. Quantitative determination of C. muridarum DNA (including study of persistence) was carried out by real time PCR. Subpopulation structure of cell population of peritoneal and vaginal lavage was evaluated by flow cytofluorometry.
  
  
  RESULTS
  Intravaginal infection of mice that had not received covinan resulted in a pronounced recruitment of cells into vaginal cavity at 24 hours after the infection. Influx of neutrophils, dendritic cells and T-lymphocytes was especially pronounced. Prior administration of covinan practically nullified cell recruitment to infection focus though partial preservation of subpopulations of activated dendritic cells and CD8+ T-cells was observed.
  
  
  CONCLUSIONS
  In mice with artificially induced by progesterone sensitivity to chlamydias the ability of recruitment to the infection focus of cells that mediate early immune reactions is reduced, that gives evidence on the importance of these reactions for infection outcome.
authors.forename: N V
authors.initials: NV
authors.lastname: Kobets
authors.forename: E A
authors.initials: EA
authors.lastname: Koroleva
authors.forename: N A
authors.initials: NA
authors.lastname: Zigangirova
mesh_terms: D000818:Animals; D018414:CD8-Positive T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D002465:Cell Movement / Q000187:drug effects / Q000276:immunology; D002690:Chlamydia Infections / Q000276:immunology* / Q000382:microbiology; D023502:Chlamydia muridarum / Q000276:immunology*; D004269:DNA, Bacterial / Q000032:analysis; D003713:Dendritic Cells / Q000187:drug effects / Q000276:immunology; D004973:Estrus Synchronization; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D018928:Immunity, Mucosal / Q000187:drug effects*; D051379:Mice; D008807:Mice, Inbred BALB C; D020556:Neutrophil Infiltration / Q000187:drug effects / Q000276:immunology; D009504:Neutrophils / Q000187:drug effects / Q000276:immunology; D011374:Progesterone / Q000008:administration & dosage / Q000031:analogs & derivatives*; D014621:Vagina / Q000276:immunology* / Q000382:microbiology
chemical_list: D004269:DNA, Bacterial; D011374:Progesterone; C017677:proligestone